EUVIMEDEUVIMED entdecken
Crossref

β-Cell miRNA-503-5p Induced by Hypomethylation and Inflammation Promotes Insulin Resistance and β-Cell Decompensation

Yuncai Zhou, Kerong Liu, Wei Tang, Yan Zhang, Yi Sun, Yangyang Wu, Ying Shi, Zhengjian Yao, Yating Li, Rongjie Bai, Rui Liang, Peng Sun und 4 weitere

Diabetes · 2024

DOI: 10.2337/db22-1044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yuncai Zhou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, MicroRNAs, Insulin-Secreting Cells. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Postdoctoral Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammation promotes pancreatic β-cell decompensation to insulin resistance because of local accumulation of supraphysiologic interleukin 1β (IL-1β) levels. However, the underlying molecular mechanisms remain elusive. We show that miR-503-5p is exclusively upregulated in islets from humans with type 2 diabetes and diabetic rodents because of its promoter hypomethylation and increased local IL-1β levels. β-Cell–specific miR-503 transgenic mice display mild or severe diabetes in a time- and expression-dependent manner. By contrast, deletion of the miR-503 cluster protects mice from high-fat diet–induced insulin resistance and glucose intolerance. Mechanistically, miR-503-5p represses c-Jun N-terminal kinase–interacting protein 2 (JIP2) translation to activate mitogen-activated protein kinase signaling cascades, thus inhibiting glucose-stimulated insulin secretion (GSIS) and compensatory β-cell proliferation. In addition, β-cell miR-503-5p is packaged in nanovesicles to dampen insulin signaling transduction in liver and adipose tissues by targeting insulin receptors. Notably, specifically blocking the miR-503 cluster in β-cells effectively remits aging-associated diabetes through recovery of GSIS capacity and insulin sensitivity. Our findings demonstrate that β-cell miR-503-5p is required for the development of insulin resistance and β-cell decompensation, providing a potential therapeutic target against diabetes. Article Highlights Promoter hypomethylation during natural aging permits miR-503-5p overexpression in islets under inflammation conditions, conserving from rodents to humans. Impaired β-cells release nanovesicular miR-503-5p to accumulate in liver and adipose tissue, leading to their insulin resistance via the miR-503-5p/insulin receptor/phosphorylated AKT axis. Accumulated miR-503-5p in β-cells impairs glucose-stimulated insulin secretion via the JIP2-coordinated mitogen-activated protein kinase signaling cascades. Specific blockage of β-cell miR-503-5p improves β-cell function and glucose tolerance in aging mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceDiabetes Mellitus, Type 2MicroRNAsInsulin-Secreting CellsHumansMiceAnimalsInsulinGlucoseInflammationMitogen-Activated Protein Kinases

Substanzen

MicroRNAsInsulinGlucoseMitogen-Activated Protein KinasesMIRN503 microRNA, humanMirn503 microRNA, mouse

Autor:innen und Institutionen

  • Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Endocrinology, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Organ Transplant Center, Tianjin First Central Hospital, Nankai University, Tianjin, China.

ORCID-Profile: Shusen Wang, Yunxia Zhu, Xiao Han

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Postdoctoral Science Foundation of Jiangsu Province

Zitieren

APA

Zhou, Y., Liu, K., Tang, W., Zhang, Y., Sun, Y., Wu, Y., Shi, Y., Yao, Z., Li, Y., Bai, R., Liang, R., Sun, P., Chang, X., Wang, S., Zhu, Y., & Han, X. (2024). β-Cell miRNA-503-5p Induced by Hypomethylation and Inflammation Promotes Insulin Resistance and β-Cell Decompensation. Diabetes. https://doi.org/10.2337/db22-1044

Vancouver

Zhou Y, Liu K, Tang W, Zhang Y, Sun Y, Wu Y, et al. β-Cell miRNA-503-5p Induced by Hypomethylation and Inflammation Promotes Insulin Resistance and β-Cell Decompensation. Diabetes. 2024. doi:10.2337/db22-1044

BibTeX
@article{Zhou2024,
  author = {Zhou, Yuncai and Liu, Kerong and Tang, Wei and Zhang, Yan and Sun, Yi and Wu, Yangyang and Shi, Ying and Yao, Zhengjian and Li, Yating and Bai, Rongjie and Liang, Rui and Sun, Peng and Chang, Xiaoai and Wang, Shusen and Zhu, Yunxia and Han, Xiao},
  title = {β-Cell miRNA-503-5p Induced by Hypomethylation and Inflammation Promotes Insulin Resistance and β-Cell Decompensation},
  journal = {Diabetes},
  year = {2024},
  doi = {10.2337/db22-1044}
}
Kostenlos starten →